CTK Biotech said on Tuesday that its ImmuView COVID-19 Antigen Home Test has received Emergency Use Authorization from the US Food and Drug Administration.

In partnership with Minnesota Department of Health, Cue’s digital service offers an integrated solution to provide COVID-19 treatment options access across all populations

Recently, Chengdu Qi Tan Technology Co., Ltd. announced that it had completed the financing round C of 700 million CNY. This round of financing was led by Mei Tuan Capital, and the Capital Great Health Fund managed by HG Capital and BioTrack Capital continued to make additional investments.

Addition of next generation sequencing research panels, bioinformatics, positions IDT to become a leading oncology research solutions provider

The US Food and Drug Administration said on Thursday it has issued Emergency Use Authorizations to two over-the-counter, at-home antigen tests for detecting the SARS-CoV-2 virus.

The US Food and Drug Administration this week granted Emergency Use Authorization for OnsiteGene's Hi-Sense COVID-19 Molecular Testing Kit 1.0.

On December 5, Haier Biomedical expanded the field of laboratory disposable plastic consumables through the acquisition of Suzhou Kangsheng Biological Co., Ltd. ("Suzhou Kangsheng" for short), accelerating the extension of smart laboratory application scenarios.

Foundation Medicine said Wednesday its FoundationOne Liquid CDx test has been approved by the US Food and Drug Administration as a companion diagnostic for epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI).

Precision Medicine Asia and the National Cancer Center Hospital East in Japan are building a lung cancer clinicopathological genomic database and screening infrastructure that spans seven countries in the Asia-Pacific region, the groups said Wednesday.

From December 15 to 22, the 7th "Guruclub Global Investment Carnival 2023" was grandly held. The Greater China Best Listed Companies has been announced and IVD companies Mindray, United Imaging Healthcare, YHLO, New Horizon Health, BGI Genomics, GenePlus, and Qitan Technology were on the list.

QuidelOrtho said on Monday that it has received Canadian approval for a rapid point-of-care assay for myocardial infarction diagnosis.

French diagnostics maker BioMérieux said on Tuesday that it has received CE marking for its Vidas Kube automated immunoassay system.

Meihua Medical completes Series B financing of over CNY 100 Million, committed to building a superior brand in microbiology testing. Non-invasive cancer early screening company OneGene completes tens of millions of CNY Series B financing.

Chinese cancer diagnostics firm SeekIn said Monday that it has received the CE mark for its PanCanSeek Cancer Mutation Detection Kit and now intends to market the test in the European Union and other regions that recognize the designation.

Medtronic said in October it plans to divest its patient monitoring and respiratory interventions businesses.